Fingerprint
Untersuchen Sie die Forschungsthemen von „Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial“. Zusammen bilden sie einen einzigartigen Fingerprint.- sortieren
- Gewicht:
- Alphabetisch
Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial
Raphael Koch, Lianne Haveman, Ruth Ladenstein, Benedicte Brichard, Heribert Jurgens, Sona Cyprova, Henk van den Berg, Wolf Hassenpflug, Anna Raciborska, Torben Ek, Daniel Baumhoer, Gerlinde Egerer, Leo Kager, Marleen Renard, Peter Hauser, Stefan Burdach, Judith V.M.G. Bovee, Angela M. Hong, Peter Reichardt, Jarmila Kruseova
- University of Münster
- Princess Máxima Center for Pediatric Oncology
- Medical University of Vienna
- Clinique Universitaire St-Luc
- Universitätsklinikum Münster
- Charles University
- University of Amsterdam
- University Medical Center Hamburg-Eppendorf
- Mother and Child Institute
- Queen Silvia Children's Hospital
- University Hospital Basel
- University Hospital Heidelberg
- Leuven University Center for Metabolic Bone Diseases
- Borsod County University Teaching Hospital
- Semmelweis University
- Leiden University Medical Centre
- Chris O’Brien Lifehouse
- The University of Sydney
- Klinikum Buch
- University Hospital of Essen
- University Children's Hospital Basel
- Ghent University Hospital
- University of Duisburg-Essen
- University Witten-Herdecke
- Royal Prince Alfred Hospital
- German Cancer Research Center
- Vilnius University
- Klinikum Ibbenbüren gGmbH
- HUS Helsinki University Hospital
- Münster University Hospital
- Lund University
- Universitätsklinikum Erlangen
- Comprehensive Cancer Center Erlangen-EMN
Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung
7
Zitate
(Scopus)